An investor specialising in early-stage medtech startups, has secured £27m towards its targeted £50m fund.
All-female general partner-led THENA Capital will target British startups developing digital healthcare solutions and medical devices.
“The UK is a key player in the global medical landscape generating game changing innovations,’ said THENA Capital co-founder and general partner Esther Reynal de Saint-Michel Richardot.
“We are thrilled to collaborate with founders, turbocharging their businesses to transform patient experiences at scale and close the gender healthcare gap.”
The medtech fund has received backing from the British Business Bank’s Enterprise Capital Funds programme, which also this week committed £50m to Elbow Beach’s new £80m climate impact fund.
Other backers of THENA’s new fund include Firebird Collective, This Day Foundation, Patrick Healy of Hellman & Friedman, Lastminute.com co-founder Baroness Martha Lane Fox and individuals from a handful of private equity and pharma firms.
“THENA Capital fills a critical funding gap in early-stage medtech, a sector vital to the UK economy and growth ambitions,” said Baron David Prior of Brampton, former chairman of NHS England and chairman of University College Hospital.
“If we are to maintain our global leadership and competitive advantage in medtech and life sciences, we must back researchers and scientists bravely bringing their innovations to market.
“THENA Capital has demonstrated a strong ability to scale these innovations for the benefit of patients and their families.”
Among the VC’s notable investments is Daye, which develops CBD-infused sanitary products, digital behavioural health platform MyMynd and Samphire Neuroscience, which develops wearable pain relief tech for women.
Register for Free
Bookmark your favorite posts, get daily updates, and enjoy an ad-reduced experience.
Already have an account? Log in
